Chemoembolization of Unresectable Hepatocellular Carcinoma With or Without Mixing the Chemotherapy With Lipiodol: Effectiveness and Safety. A Prospective and Randomized Clinical Trial

Trial Profile

Chemoembolization of Unresectable Hepatocellular Carcinoma With or Without Mixing the Chemotherapy With Lipiodol: Effectiveness and Safety. A Prospective and Randomized Clinical Trial

Recruiting
Phase of Trial: Phase III

Latest Information Update: 09 Dec 2016

At a glance

  • Drugs Ethiodized oil (Primary) ; Antineoplastics; Lobaplatin; Polyvinyl alcohol
  • Indications Liver cancer
  • Focus Therapeutic Use
  • Most Recent Events

    • 06 Dec 2016 Planned End Date changed from 1 Aug 2016 to 1 Aug 2018.
    • 06 Dec 2016 Planned primary completion date changed from 1 Aug 2016 to 1 Aug 2018.
    • 03 Apr 2016 Planned End Date changed from 1 Aug 2018 to 1 Aug 2016 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top